Memantine Hydrochloride Extended-Release Capsules
Major Pharmaceuticals is recalling 7 mg Memantine Hydrochloride Extended-Release Capsules due to failed dissolution specifications.
Contact your healthcare provider or pharmacist if you have concerns about your medication. Do not stop taking your medication without consulting a medical professional.
Why it was recalled
Major Pharmaceuticals is recalling Memantine Hydrochloride Extended-Release Capsules, 7 mg, due to failed dissolution specifications. This product was distributed nationwide.
Is mine affected?
Check the NDC or UPC and strength printed on the package. Yours is affected if it matches one below.
Memantine Hydrochloride Extended-Release, Capsules, 7 mg, 100 Capsules (10 x 10 blister packs), Rx only, Packaged and Distributed by: Major Pharmaceuticals, Indianapolis, IN 46268, NDC 0904-6734-61
- Recall #
- D-0485-2026
Where it was sold
Distributed nationwide.
Official source
Other recent recalls from The Harvard Drug Group LLC
Editorial summary by Recall Canary · last updated 2026-06-11 · primary source: U.S. Food and Drug Administration · severity reflects the agency's published classification